By Jeff Overley (September 19, 2014, 2:24 PM EDT) -- A fiery feud in California federal court between the U.S. Department of Justice and Pharmaceutical Research and Manufacturers of America shows the gloves are finally off in a fight that will shape the future of False Claims Act litigation, experts say, with opposing sides clashing over whether the First Amendment always shields honest off-label promotion.
The battle playing out in recent weeks in Solis v. Millennium comes almost two years after the Second Circuit's monumental Caronia ruling, which erased a pharmaceutical salesman's misbranding conviction after finding he'd been prosecuted for truthful speech, not separate conduct related to his speech.
That decision raised doubts...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!